TP53的损失在结直肠癌中造成治疗脆弱性
Yunhua Liu1, Xinna Zhang2, Cecil Han1
1Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
Nature
|April 23, 2015
概括
对TP53的基因组删除通常会使RNA聚合酶II的关键基因POLR2A失活. 抑制POLR2A可以选择性地向TP53损失的癌细胞,为常见的人类癌症提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- TP53是一种瘤抑制基因,在人类癌症中经常被禁用.
- 恢复p53功能是癌症治疗的目标,但复杂的信号通路阻碍了进展.
- TP53的基因组删除可以与邻近必需基因的损失同时发生.
研究的目的:
- 识别与TP53共删除的基因并探索它们的治疗潜力.
- 研究POLR2A在TP53缺失的癌症中的作用.
- 评估α-amanitin及其抗体-药物合物作为向癌症疗法.
主要方法:
- 对癌症基因组图谱 (TCGA) 和癌症细胞系百科全书 (CCLE) 数据库的分析.
- 在结直肠癌中对POLR2A的基因表达和拷贝数分析.
- 在体外和体内使用α-amanitin,小干扰RNA和抗体-药物联合体的研究.
主要成果:
- POLR2A经常与TP53一起被共同删除,其表达与基因拷贝数相关.
- 抑制POLR2A可以选择性地抑制结肠直肠癌细胞的增殖和存活,并导致半性TP53损失.
- 在临床前模型中,α-amanitin结合抗体-药物结合物显示出高疗效和降低毒性.
结论:
- 向POLR2A代表了针对TP53删除的癌症的新治疗策略.
- α-阿曼因的抗体药物联体为克服毒性限制提供了一个有希望的方法.
- 这种方法有可能用于治疗具有常见基因组改变的人类癌症.
相关概念视频
02:23Abnormal Proliferation
5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
01:12Loss of Tumor Suppressor Gene Functions
6.4K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.4K
01:12Loss of Tumor Suppressor Gene Functions
2.1K
2.1K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
10.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.4K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
3.1K
3.1K
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
70
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
70